Literature DB >> 23737348

CSF viral escape in a patient with HIV-associated neurocognitive disorder.

Michael N Khoury1, C Sabrina Tan, Marcia Peaslee, Igor J Koralnik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23737348      PMCID： PMC3759614          DOI： 10.1007/s13365-013-0175-9

Source DB:  PubMed          Journal:  J Neurovirol        ISSN： 1355-0284            Impact factor:   2.643


× No keyword cloud information.
  11 in total

Review 1.  HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era.

Authors:  Olivier Lambotte; Kumaran Deiva; Marc Tardieu
Journal:  Brain Pathol       Date:  2003-01       Impact factor: 6.508

2.  Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry.

Authors:  K Takahashi; S L Wesselingh; D E Griffin; J C McArthur; R T Johnson; J D Glass
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

3.  CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy.

Authors:  Ronald J Ellis; Jayraan Badiee; Florin Vaida; Scott Letendre; Robert K Heaton; David Clifford; Ann C Collier; Benjamin Gelman; Justin McArthur; Susan Morgello; J Allen McCutchan; Igor Grant
Journal:  AIDS       Date:  2011-09-10       Impact factor: 4.177

4.  Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.

Authors:  Marlene Smurzynski; Kunling Wu; Scott Letendre; Kevin Robertson; Ronald J Bosch; David B Clifford; Scott Evans; Ann C Collier; Michael Taylor; Ronald Ellis
Journal:  AIDS       Date:  2011-01-28       Impact factor: 4.177

5.  Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.

Authors:  Samanta Simioni; Matthias Cavassini; Jean-Marie Annoni; Aline Rimbault Abraham; Isabelle Bourquin; Véronique Schiffer; Alexandra Calmy; Jean-Philippe Chave; Ezio Giacobini; Bernard Hirschel; Renaud A Du Pasquier
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

6.  Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.

Authors:  Michael J Peluso; Francesca Ferretti; Julia Peterson; Evelyn Lee; Dietmar Fuchs; Antonio Boschini; Magnus Gisslén; Nancy Angoff; Richard W Price; Paola Cinque; Serena Spudich
Journal:  AIDS       Date:  2012-09-10       Impact factor: 4.177

Review 7.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

8.  HIV Dementia Scale: a rapid screening test.

Authors:  C Power; O A Selnes; J A Grim; J C McArthur
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-03-01

9.  Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort.

Authors:  Maiko Sakamoto; Thomas D Marcotte; Anya Umlauf; Donald Franklin; Robert K Heaton; Ronald J Ellis; Scott Letendre; Terry Alexander; J A McCutchan; Erin E Morgan; Steven P Woods; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David Simpson; Igor Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2013-01-01       Impact factor: 3.731

10.  Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia.

Authors:  Gretja Schnell; Serena Spudich; Patrick Harrington; Richard W Price; Ronald Swanstrom
Journal:  PLoS Pathog       Date:  2009-04-24       Impact factor: 6.823
View more
  14 in total

1.  Global HIV neurology: a comprehensive review.

Authors:  Kiran T Thakur; Alexandra Boubour; Deanna Saylor; Mitashee Das; David R Bearden; Gretchen L Birbeck
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

2.  Better Antiretroviral Central Nervous System Penetration is Not Associated with Reduced Chronic Pain in People Living with Human Immunodeficiency Virus.

Authors:  Nathaniel M Robbins; Kanokporn Chaiklang; Khuanchai Supparatpinyo
Journal:  Antiinfect Agents       Date:  2016

Review 3.  Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.

Authors:  Francesca Ferretti; Magnus Gisslen; Paola Cinque; Richard W Price
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

Review 4.  Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.

Authors:  Suzi Hong; William A Banks
Journal:  Brain Behav Immun       Date:  2014-10-22       Impact factor: 7.217

5.  Childhood trauma and genetic variation in the DAT 40-bp VNTR contribute to HIV-associated neurocognitive disorders.

Authors:  Aqeedah Abbas Roomaney; Jacqueline Samantha Womersley; Patricia Cathryn Swart; Georgina Spies; Soraya Seedat; Sian Megan Joanna Hemmings
Journal:  IBRO Neurosci Rep       Date:  2021-12-08

Review 6.  Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism.

Authors:  Maria F Chen; Alexander J Gill; Dennis L Kolson
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

Review 7.  Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.

Authors:  Andrea Calcagno; Giovanni Di Perri; Stefano Bonora
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

8.  Incidence of symptomatic CSF viral escape in HIV infected patients receiving atazanavir/ritonavir (ATV/r)-containing ART: a tertiary care cohort in western India.

Authors:  Atul K Patel; Ketan K Patel; Swati Gohel; Ambuj Kumar; Scott Letendre
Journal:  J Neurovirol       Date:  2018-04-24       Impact factor: 2.643

9.  Relevance of retrovirus quantification in cerebrospinal fluid for neurologic diagnosis.

Authors:  Carolina Rosadas; Marzia Puccioni-Sohler
Journal:  J Biomed Sci       Date:  2015-08-08       Impact factor: 8.410

10.  Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients.

Authors:  Francesca Ferretti; Alba Bigoloni; Laura Passeri; Laura Galli; Valeria Longo; Simonetta Gerevini; Vincenzo Spagnuolo; Magnus Gisslen; Henrik Zetterberg; Dietmar Fuchs; Dario Cattaneo; Giada Caramatti; Adriano Lazzarin; Paola Cinque; Antonella Castagna
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.